Recognify Life Sciences

Developing a treatment for Cognitive Impairment associated with Schizophrenia.

Berlin Germany (HQ)

Date	Investors	Amount	Round
Jan 2021	ATAI Life Sciences	N/A	Acquisition
Total Funding		-

Recent News about Recognify Life Sciences